✨ Medicines and Tax Notices




NEW ZEALAND GAZETTE, No. 140

10 OCTOBER 2013


Product:

Ristova

Active Ingredient:
Rituximab 10mg/mL

Dosage Form:
Concentrate for infusion

New Zealand Sponsor:
Roche Products (NZ) Limited

Manufacturers:
Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Basel, Switzerland
Genentech Inc, California, United States of America

Dated this 8th day of October 2013.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go6564


Inland Revenue

Income Tax Act 2007

Resident Withholding Tax on Interest

Cancelled certificates of exemption for the period 01/07/13 to 30/09/13

[table of cancelled RWT certificate numbers omitted]

Reissued certificates of exemption for the period 01/07/13 to 30/09/13

[table of reissued RWT certificate numbers omitted]

go6561



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2013, No 140





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Ristova

πŸ₯ Health & Social Welfare
8 October 2013
Medicines, Distribution Consent, Rituximab, Ristova
  • Dr Don Mackie, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ’° Resident Withholding Tax on Interest Certificates

πŸ’° Finance & Revenue
Tax, Resident Withholding Tax, Certificates of Exemption